Hypercholesterolemia Induces Side-Specific Phenotypic Changes and Peroxisome Proliferator-Activated Receptor-γ Pathway Activation in Swine Aortic Valve Endothelium

被引:33
|
作者
Guerraty, Marie A.
Grant, Gregory R. [2 ]
Karanian, John W. [4 ]
Chiesa, Oscar A. [4 ]
Pritchard, William F. [4 ]
Davies, Peter F. [1 ,3 ]
机构
[1] Univ Penn, Inst Med & Engn, Vagelos Labs 1010, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] US FDA, Lab Cardiovasc & Intervent Therapeut, Laurel, MD USA
基金
美国国家卫生研究院;
关键词
Valves; Endothelium; Cholesterol; Genes; Molecular Biology; ACID-BINDING PROTEIN; SHEAR-STRESS; HEART-VALVES; CELLS; ATHEROSCLEROSIS; CALCIFICATION; COREPRESSORS; PERSPECTIVE; EXPRESSION; APOPTOSIS;
D O I
10.1161/ATVBAHA.109.198549
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The endothelium of healthy aortic valves expresses different phenotypes on the aortic and ventricular sides. On the aortic side, which is susceptible to aortic valve sclerosis, there is a balanced coexpression of both propathological and protective pathways. Side-specific global gene expression can address endothelial phenotype balance in early aortic valve sclerosis. Methods and Results-Adult male swine were fed a hypercholesterolemic or an isocaloric normal diet for 2-week and 6-month periods. Hypercholesterolemia induced localized lipid insudation confined to the aortic side of the leaflet. Transcript profiling of valve endothelial populations showed that the susceptible aortic side was more sensitive to 2-week hypercholesterolemia than the ventricular side (1,325 vs 87 genes were differentially expressed). However, greater sensitivity was not evidence of a dysfunctional phenotype. Instead, pathway analyses identified differential expression of caspase 3-, peroxisome proliferator-activated receptor gamma-, TNF-alpha-, and nuclear factor-kappa B-related pathways that were consistent with a protective endothelial phenotype. This was confirmed at the protein level at 2 weeks and persisted at 6 months. Conclusions-In a large animal model at high spatial resolution, endothelium on the pathosusceptible side of the aortic valve leaflet is responsive to hypercholesterolemia. Transcript profiles indicative of a protective phenotype were induced and persisted on the side prone to aortic valve sclerosis. (Arterioscler Thromb Vasc Biol. 2010;30:225-231.)
引用
收藏
页码:225 / 231
页数:7
相关论文
共 50 条
  • [1] Activation of peroxisome proliferator-activated receptor-γ pathway inhibits osteoclast differentiation
    Mbalaviele, G
    Abu-Amer, Y
    Meng, A
    Jaiswal, R
    Beck, S
    Pittenger, MF
    Thiede, MA
    Marshak, DR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) : 14388 - 14393
  • [2] Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation
    Toral, Marta
    Romero, Miguel
    Perez-Vizcaino, Francisco
    Duarte, Juan
    Jimenez, Rosario
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (02): : H189 - H200
  • [3] Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone
    Camp, HS
    Li, O
    Wise, SC
    Hong, YH
    Frankowski, CL
    Shen, XQ
    Vanbogelen, R
    Leff, T
    DIABETES, 2000, 49 (04) : 539 - 547
  • [4] Activation of peroxisome proliferator-activated receptor-γ inhibits differentiation of preosteoblasts
    Khan, E
    Abu-Amer, Y
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2003, 142 (01): : 29 - 34
  • [5] The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
    Mercedes Ricote
    Andrew C. Li
    Timothy M. Willson
    Carolyn J. Kelly
    Christopher K. Glass
    Nature, 1998, 391 : 79 - 82
  • [6] The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
    Ricote, M
    Li, AC
    Willson, TM
    Kelly, CJ
    Glass, CK
    NATURE, 1998, 391 (6662) : 79 - 82
  • [7] Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-γ agonist in hypercholesterolemia
    Tao, L
    Liu, HR
    Gao, E
    Teng, ZP
    Lopez, BL
    Christopher, TA
    Ma, XL
    Batinic-Haberle, I
    Willette, RN
    Ohlstein, EH
    Yue, TL
    CIRCULATION, 2003, 108 (22) : 2805 - 2811
  • [8] Deletion of peroxisome proliferator-activated receptor-α induces an alteration of cardiac functions
    Loichot, Cecile
    Jesel, Laurence
    Tesse, Angela
    Tabernero, Antonia
    Schoonjans, Kristina
    Roul, Gerard
    Carpusca, Irina
    Auwerx, Johan
    Andriantsitohaina, Ramaroson
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (01): : H161 - H166
  • [9] Antifibrotic effect by activation of peroxisome proliferator-activated receptor-γ in corneal fibroblasts
    Pan, Hongwei
    Chen, Jiansu
    Xu, Jintang
    Chen, Miaojiao
    Ma, Rong
    MOLECULAR VISION, 2009, 15 (245): : 2279 - 2286
  • [10] Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis
    Misra, Parimal
    Reddy, Janardan K.
    BIOCHIMIE, 2014, 98 : 63 - 74